Clinical evaluation of 67Ga-citrate scanning in the oral region

https://doi.org/10.1016/0030-4220(75)90381-3Get rights and content

Abstract

Gallium-67-citrate was administered to thirty-nine patients who had a variety of benign, malignant, and inflammatory lesions of the oral region. The gallium-67 scintigram was noted to be valuable in the diagnosis of maxillary carcinoma, parotid carcinoma, and malignant lymphoma. Clinically, it is possible to differentiate malignant tumors from benign ones with the aid of 67Ga scanning. It is difficult, however, to differentiate malignant tumors from inflammatory lesions. At present, it is difficult to detect the small malignant lesion by means of a 67Ga scintigram.

References (12)

  • S.G. Vaidya

    Localisation of Gallium-67 in Malignant Neoplasms

    Lancet

    (1970)
  • C.L. Edwards et al.

    Tumor Scanning With 67Ga Citrate

    J. Nucl. Med

    (1969)
  • C.L. Edwards et al.

    Scanning Malignant Neoplasms With Gallium 67

    J.A.M.A

    (1970)
  • H.S. Winchell

    Visualization of Tumors in Humans Using 67Ga-Citrate and the Anger Whole-Body Scanner, Scintillation Camera and Tomographic Scanner

    J. Nucl. Med

    (1970)
  • Y. Ito

    67Ga Tumor Scanning and Its Mechanism Studied in Rabbits

    Radiology

    (1971)
  • H. Langhammer

    67Ga for Tumor Scanning

    J. Nucl. Med

    (1972)
There are more references available in the full text version of this article.
View full text